Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Investment Holdings Co., Ltd. (SIHC) is a massive state-owned investment holding company and a Fortune Global 500 enterprise based in Shenzhen, China. While it operates across diverse sectors including finance, technology, and urban development, it is a pivotal player in the life sciences and healthcare industry through its "Big Health" strategic focus. SIHC manages and invests in major biomedical infrastructure, such as the Shenzhen Biomedicine Innovations Industrial Park, and serves as a primary investment platform for the city's emerging biotech and pharmaceutical clusters. The company acts as a key financier and incubator for numerous innovative biotech firms, providing capital, industrial space, and strategic support to accelerate drug discovery and medical device development in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Investment.